Synecor evolved from the confluence of several synergistic strategic relationships, initially in the field of interventional cardiology, but has expanded its field to include all medical specialties such as obesity, spine therapeutics, and more. Synecor was founded by Dr. Richard Stack after two decades of collaboration with leading cardiologists, clinician-inventors, and scientists from across the nation and as an outgrowth of close working relationships among corporate leaders in the medical device industry, and experts at Duke University. Mr. William Starling, a well-known Silicon Valley medical device entrepreneur/executive with a successful 27-year career in the high technology cardiovascular device industry, partnered with Dr. Stack to co-manage Synecor and form strategic relationships with leading venture capital partnerships (Delphi Ventures and Frazier & Company) and a leading investment bank (Deutsche Banc Alex. Brown). To complete the partner team, Dr. Stack and Mr. Starling also partnered with major life sciences corporations with vast resources and knowledge (Guidant and GE Medical Systems).

Hangzhou Weiqiang Medical Technology Co., Ltd., established on 2016-05-03, Business scope includes technology development,technical consulting,Achievement transfer:medical technology,Class I medical device,Class III medical devices;Production,wholesale,retail:Class I medical device,Class III medical devices;Import and export of goods and technology(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license)(Except those involving the implementation of special access management measures stipulated by the state)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Hanyu Medical Technology Co., Ltd. operates as a medical device company. It focuses on research, development and commercialization of medical devices in the field of structural heart diseases with a special focus in the transcatheter mitral valve. The company was founded by Yufeng Dai and Huixian Yang on December 22, 2016 and is headquartered in Shanghai, China.

PQ Bypass is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions. PQ Bypass is a former Company-In-Residence at the Fogarty Institute for Innovation and is operated by recognized leaders in the medical device industry. Our executive team members have held senior leadership positions at companies including Medtronic, Abbott, Johnson & Johnson, Covidien, and Stryker and also have extensive experience developing medical devices for venture-backed startups such as Evalve, AccessClosure, Altura, and DVI.

Tendyne Holdings, Inc. is a clinical stage medical device company focused on the development of minimally invasive therapies for the treatment of mitral regurgitation. Mitral regurgitation is a condition that afflicts hundreds of thousands of individuals worldwide every year. Formed in 2010, their first product concept is a transcatheter mitral valve replacement prosthesis for the treatment of mitral regurgitation. The intent is for the valve to be deployed and secured with no disruption to the native mitral annulus while preserving the sub-valvular apparatus. Placement of the valve is intended to be completed transapically in a simple procedure where the implanting physician is able to re-position, remove, and re-deploy their valve throughout the procedure.

Pipeline Medical Technologies, Inc. develops transcatheter device for heart surgical treatments. The company was founded by Steven Bolling and is headquartered in Santa Rosa, CA.

Tellyes Scientific is a comprehensive technology enterprise that integrates the research and development, production, and sales of modern medical teaching products. The company engages in innovation, research, and development activities in a number of important fields with training software and a traditional Chinese medicine training system supported by contemporary technology, and offers the market twelve series and more than a thousand different types of medical virtual teaching products based on the aforementioned technologies.

Part of Medtronic Plc, DLP, Inc. is a company headquartered in Grand Rapids, MI, involved in surgical and medical instruments and apparatus. The firm was acquired by Medtronic, Inc., part of Medtronic Plc since January 2015, on March 18, 1994 for $128 million.

Argon Medical Devices, Inc. manufactures specialty medical products. It offers arterial lines, endomyocardial biopsy, percutaneous drainage, urology, bone and bone marrow biopsy, fluid management systems, critical care, pressure monitoring, mammography, drapes and covers, mechanical thrombectomy, and transjugular liver biopsy products. The company was founded in 1972 and is headquartered in Frisco, TX.

Shanghai Lanmai Medical Technology Co., Ltd., established on 2018-01-10, The scope of business includes engaging in technical consulting in the field of medical technology,R&D of medical devices,Sales,Business Consulting,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Edwards Lifesciences AG, a subsidiary of Edwards Lifesciences Corp., is a Swiss company located in Nyon that manufactures and distributes healthcare equipment.

VADovations is an Oklahoma-based start-up company working to build a miniature ventricular assist device (VAD), a mechanical blood pump, which is smaller and lighter than ones currently on the market. The company develops a miniature blood pump which enables less invasive surgery to implant thereby shortening hospitalization time from three weeks to four days.

Sorin Biomedical is a health care provider with research,develop and deliver reliable therapeutic solutions.

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.